In the DSS colitis mouse model, liraglutide-treated mice exhibited significantly lower caecal occludin mRNA levels and higher TNF-α mRNA levels compared to controls, while RegIIIβ and IL-33 mRNA levels showed an increased trend. The gene discussed is IL33; the disease is colitis.